Your browser doesn't support javascript.
loading
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study.
Idolazzi, L; Fassio, A; Viapiana, O; Rossini, M; Adami, G; Bertoldo, F; Antoniazzi, F; Gatti, D.
Affiliation
  • Idolazzi L; Rheumatology Unit, Department of Medicine, University of Verona, Italy. Electronic address: luca.idolazzi@univr.it.
  • Fassio A; Rheumatology Unit, Department of Medicine, University of Verona, Italy.
  • Viapiana O; Rheumatology Unit, Department of Medicine, University of Verona, Italy.
  • Rossini M; Rheumatology Unit, Department of Medicine, University of Verona, Italy.
  • Adami G; Rheumatology Unit, Department of Medicine, University of Verona, Italy.
  • Bertoldo F; Internal Medicine Unit, Department of Medicine, University of Verona, Italy.
  • Antoniazzi F; Pediatric Clinic, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, Pediatric Division, University of Verona, Verona, Italy.
  • Gatti D; Rheumatology Unit, Department of Medicine, University of Verona, Italy.
Bone ; 103: 144-149, 2017 Oct.
Article in En | MEDLINE | ID: mdl-28684193

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteogenesis Imperfecta / Bone and Bones / Bone Density / Diphosphonates / Bone Density Conservation Agents Limits: Adolescent / Child / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Bone Journal subject: METABOLISMO / ORTOPEDIA Year: 2017 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteogenesis Imperfecta / Bone and Bones / Bone Density / Diphosphonates / Bone Density Conservation Agents Limits: Adolescent / Child / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Bone Journal subject: METABOLISMO / ORTOPEDIA Year: 2017 Document type: Article Country of publication: United States